ERRγ, a Novel Biomarker, Associates with Pathoglycemia of Endometrial Cancer to Predict Myometrial Invasion

Figure 5

(a) Serum levels of ERRγ in EC patients and healthy controls. (b) Serum levels of ERRγ in different myometrial invasion depth groups. (c) Serum levels of ERRγ in different serum FBG groups. (d–f) Correlation analysis between serum ERRγ and other indicators in EC patients and healthy controls. FBG: fasting blood glucose.

(a)

(b)

(c)

(d)

(e)

(f)